9th Annual Biomarkers Congress
2011 AHPBA Americas Post Graduate Course
Clinica Alemana
Calle El Rodeo 1900 Santiago, Chile (0)2 753 1700
Santiago, Santiago
http://www.mdanderson.org/education-and-research/education-and-training/schools-and-programs/cme-conference-management/conferences/cme/conference-management-2011-ahpba-americas-postgraduate-course.html
The vision of The University of Texas MD Anderson Cancer Center is to enhance the excellence, value, safety and efficiency of our patient care.
The goal of this conference is to review the current indications for surgical treatment and adjuvant therapy for a number of hepatobiliary topics.
These include indications for minimally invasive hepatobiliary surgery, surgical and medical management of parasitic liver disease, the role of ablative technologies in hepatobiliary surgery for malignancy, and optimal multi-modality treatment strategies for hepatocellular carcinoma. By merging the expertise of hepatobiliary surgeons in both North and South America, the conference is aimed at addressing the identified knowledge gaps for both groups. At the conclusion of the conference, attendees should leave with a higher level of understanding and competence in the diagnosis and management of these disorders.
Educational

At the conclusion of this educational activity, participants should be able to
• Appropriately apply minimally invasive hepatobiliary surgical techniques (Knowledge, Competence, and Performance);
• Appropriately select and sequence the multiple treatment modalities available for the management of primary and metastatic hepatobiliary malignancies (Knowledge, Competence, and Performance);
• Appropriately implement the most up to date strategies in the management of cystic liver disease, (Knowledge, Competence, Performance and Patient Outcomes).

http://www.mdanderson.org/education-and-research/education-and-training/schools-and-programs/cme-conference-management/conferences/cme/conference-management-2011-ahpba-americas-postgraduate-course.html

Schedule of Presentations:

Thursday, June 30, 2011
13:00:00 Introduction, Remarks from Leadership, Presentation of Young HPB Surgeons on Scholarship Juan Hepp, Jean-Nicolas Vauthey, Reid Adams
13:25:00 Session1 | Multidisciplinary Care of the Patient with Gallbladder and Bile Duct Malignancy Elijah Dixon, Timothy Pawlik, Nestor Gomez, Xabier de Aretxabala
13:30:00 Surgical Management of Gallbladder Cancer | Historical Perspectives and Current Update Xabier de Aretxabala
13:50:00 Recent Advances in Multimodality Therapy for Hepatopancreatobiliary Malignancy Frederico Costa
14:10:00 Recent Advances in Surgical Management of Hilar and Intrahepatic Cholangiocarcinoma Mike House
14:30:00 Liver Transplantation for Cholangiocarcinoma | Lessons Learned and Future Directions Thomas Aloia
14:45:00 Panel Discussion & Question and Answer Session
15:00:00 Break
15:10:00 Session 2 | Future Perspectives on Treatment Sequencing for Hepatocellular Carcinoma Steven A Curley, Eduardo de Santibañes, Nicolás Jarufe
15:15:00 Where Do We Go Next? Top 5 Future Clinical Trials in Hepatocellular Carcinoma Ahmed Kaseb
15:35:00 Resection and Transplantation for Hepatocellular Carcinoma | The South American Experience Oscar Cesar Imventarza
15:55:00 Advanced Interventional and Surgical Techniques to Improve Resectability for Patients with Hepatocellular Carcinoma Michael D’Angelica
16:15:00 Methods to Improve “Transplantability” for Hepatocellular Carcinoma William Chapman
16:30:00 Panel Discussion & Question and Answer Session
16:45:00 Break
17:00:00 Invocation of AHPBA Chile Chapter Reid Adams, Jean-Nicolas Vauthey, Xabier de Aretxabala, Mario Uribe
19:00:00 Reception and Dinner
Friday, July 1, 2011
08:40:00 Session 3 | Medical and Surgical Management of Cystic Liver Disease | Parasitic and Congenital Reid Adams, Marcel Machado, Carlos Chan
08:45:00 Surgical Management of Benign and Infectious Cystic Disease of the Liver Juan Hepp
09:05:00 Management of Parasitic Liver Disease | The Amazonian Experience
09:25:00 Polycystic Liver Disease | Fenestration, Resection, and Transplantation David M. Nagorney
09:45:00 Indications and Experience with Minimally Invasive Surgery for Cystic Liver Disease Juan Pekolj
10:00:00 Panel Discussion & Question and Answer Session
10:15:00 Break
10:25:00 Session 4 | Current Molecular Diagnostic and Management Strategies for Colorectal Liver Metastases Thomas Aloia, Felipe Coimbra, Javier Lendoire
10:30:00 Chemotherapy for Colorectal Liver Metastases | Where We Have Been and Where We are Going Paulo Hoff
10:50:00 New Technologies for Liver-Directed Therapy | Microwave Ablation, Radioembolization and Drug-Eluting Beads Robert Martin
11:10:00 Management of Synchronous Colorectal Liver Metastases Javier Lendoire
11:30:00 The Expanding Role for Portal Vein Embolization and Chemotherapy Prior to Resection of Colorectal Liver Metastases Jean-Nicolas Vauthey
11:45:00 Panel Discussion & Question and Answer Sessions
11:55:00 Session 5 | Minimally Invasive Techniques in Hepatobiliary Surgery | North and South Horacio Asbun, Paulo Herman, Jorge León
12:00:00 Lunch
13:00:00 Laparoscopic Approaches to SegmentectomyVersus Hemihepatectomy Andrew Gumbs
13:20:00 Robotic Hepatectomy | Current Role and Future Directions in Hepatobiliary Surgery Ferraz-Neto Ben-Hur Ferraz
13:40:00 Minimal Access Approaches to Benign Disorders of the Biliary Ducts | Cysts, Strictures & Stones Horacio Asbun
14:00:00 Minimally Invasive Liver Resection for Gallbladder Cancer | A Novel Strategy Jorge León
14:15:00 Panel Discussion & Question and Answer Session
14:30:00 Break
16:10:00 Session 6 | Interesting Case/Video Presentation Competition and Case Studies I-VI Horacio Asbun, Mario Uribe, Oscar Cesar Imventarza
16:15:00 Video Awards and Closing Remarks Juan Hepp, Xabier de Aretxabala, Jean-Nicolas Vauthey, Reid Adams
4th Annual Pharma R&D Asia Congress
About Us | Privacy Policy | Site Map | FAQs | Advertise With Us | Community
BiotechScienceNews.com promotes research and ranks life scientists working in the life science spectrum involving biotechnology,
drug discovery, genomics, microbiology, neuroscience, medicine, pharmacology, cell biology, and molecular biology.